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Background: Central obesity has been recognized as a main risk factor for cardiovascular (CV) events. Three
popular central obesity indices are waist circumference, waist-to-hip ratio (WHR), and waist-to-height ratio;
abdominal volume index and conicity index are 2 recent novel obesity indices. The main aim of this study is to
determine the performance of these indices to best predict 10-year CV events.
Hypothesis: Some obesity indices can be used to predict cardiovascular risk.
Methods: In total, 3199 subjects (age range, 40–79 years) were enrolled in this cross-sectional study. The
American College of Cardiology/American Heart Association and Framingham risk score tools were used to
estimate the 10-year CV events. Receiver operating characteristic curve analysis was used to determine the
optimal discriminator(s) among the central obesity measures in the estimation of a 10-year risk of CV events
≥7.5%, ≥10%, and ≥20% separately.
Results: Among the 5 central obesity indices, conicity index showed the most discriminatory power in
estimation of a 10-year CV risk. In men, based on the American College of Cardiology/American Heart
Association tool, the areas under the curve (AUCs) were from 0.671 to 0.682 based on the 3 above thresholds,
whereas with the Framingham tool, AUCs were from 0.651 to 0.659. In women, all AUCs were>0.7. Our results
also showedWHR to be an almost comparable discriminator of CV disease risk in the Iranian study population.
Conclusion: Conicity index and WHR had a more discriminatory accuracy for 10-year CV events compared with
the other obesity indices.
Introduction
Cardiovascular (CV) diseases are the leading cause of
death worldwide.1 The prevalence of CV diseases varies
geographically and culturally. The Middle East and areas in
Eastern Europe possibly contribute to the highest CV death
rates in the world, with Iran probably bearing a greater
affliction relative to other countries in this region.2
Although the rates of fatal and nonfatal ischemic heart
diseases have decreased, their overall burden has increased
due to population growth and aging in most countries
between 1990 and 2010.3 Several powerful CV risk-
assessment tools were developed to assist clinicians in the
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assessment of CV disease at the individual level and also to
help health policymakers estimate its burden in future years
at community level.4,5 One of the best-known tools is the
Framingham instrument, although the American College of
Cardiology and American Heart Association (ACC/AHA)
have jointly introduced a new instrument recently to
assess 10-year risk of CV events.4,5 The Framingham
and ACC/AHA tools use identical variables but different
approaches to assess the risk of CV events over the next
decade.
Neither the Framingham nor the ACC/AHA instruments
have included obesity indices to assess the risk of
CV events, despite well-documented evidence for the
association between central obesity and CV diseases.6–8
To measure central obesity, various indices have been
suggested; among them, waist circumference (WC), waist-
to-hip ratio (WHR), and waist-to-height ratio (WHtR) are
regarded as the most popular indices that are widely
applied in clinical settings. More recent indices, abdominal
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volume index (AVI) and conicity index (CI), which are
calculated on simple data such as weight, height, WC, and
hip circumference (HC), have also been introduced.9–11
Because of the undeniable association between central
obesity and CV disease, this study sought to determine and
compare the discriminatory performance of the 5mentioned
indices of central obesity—WC, WHR, WHtR, AVI, and
CI—as instruments of screening to best estimate 10-year
CV risk in men and women based on 2 risk-prediction tools
(Framingham and ACC/AHA) in northern Iran.
Methods
For this cross-sectional study, we used the baseline data
of a larger study, a population-based cohort that was
started in September 2008 in Amol, a densely populated
city of northern Iran. In total, 6140 subjects, age 10 to 90
years, participated in the main cohort study. Sampling has
been described elsewhere.12 All participants gave informed
consent for the study, which was approved by the Ethics
Committee of Iran University of Medical Sciences. From
the 6140 participants in the main cohort study, based on our
inclusion criteria for this cross-sectional study (age 40–79
years), the data of 3199 subjects were analyzed. A schematic
diagram of the study population is demonstrated in Figure 1.
Trained health care providers measured blood pressure
and anthropometric data, including weight, height, WC, and
HC. Before weight measurement, calibration of weighing
scales was performed with 5-kg weights. Moreover, the
removal of excess clothes and shoes was recommended to
assure accurate measurements. Height wasmeasured while
the participants were standing against a wall with their heels
and buttocks in contact with the wall. Waist circumference
was determined, in duplicate, at the midpoint between the
lowest costal ridge and the upper border of the iliac crest. In
the event of a>2-cm discrepancy, then a thirdmeasurement
was performed and the average of the 2 nearest values was
reported as WC. Hip circumference was measured at the
largest circumference between waist and knee. Both WC
and HC were done with a nonstretchable and accurately
calibrated scale with 0.5-cm precision.
Other indices of central obesity were calculated using
following formulas:
WHR = waist (cm) / hip (cm)
WHtR = waist (cm) / height (cm)
CI = waist (m) /
[
0.109 ×
√
weight
(
kg
)
/ height (m)
]
AVI =
{
2 × waist2 (cm)2 + 0.7
× [waist (cm) − hip (cm)]2} /1000
Systolic and diastolic blood pressures were determined
using a properly fitted cuff with participants in sitting
position, with back supported and legs uncrossed.
A venous blood sample was drawn from each partici-
pant following 12-hour fasting to assess fasting blood sugar
(FBS) and lipid profiles. All tests, including FBS, triglyc-
erides (TG), high-density lipoprotein cholesterol (HDL-
C), low-density lipoprotein cholesterol (LDL-C), and total
cholesterol, were assessed enzymatically using the BS-200
auto analyzer (Mindray, Nanshan, Shenzhen, China). Ten
percent of the blood samples were evaluated by the Iranian
National Reference Laboratory, with the coefficients of vari-
ation being between 1.7% and 3.8% of all laboratory values.
To estimate the 10-year risk for CV events, the risks
were calculated separately for men and women based
on ACC/AHA equations and Framingham risk scores.
In the ACC/AHA approach, race-specific and sex-specific
multivariate equations were used to estimate the 10-year
risk for a first severe atherosclerotic cardiovascular disease
(ASCVD) event, including coronary heart disease (CHD),
death, nonfatal myocardial infarction, and fatal or nonfatal
stroke, in non-Hispanic African Americans and non-Hispanic
American whites age 40 to 79 years. We used the sex-
specific non-Hispanic American white version of pooled
cohort multivariate equations to calculate 10-year risk for a
first severe ASCVD event. To estimate the prevalence of a
10-year CV risk≥7.5%,≥10%, and≥20%, each calculated risk
was converted to a dichotomous scale based on thresholds
of 7.5%, 10%, and 20%.
Receiver operating characteristic (ROC) curves were
plottedwith the use of each value of the central obesity index
as a possible cutoff point to compute related sensitivities and
false-positive rates. The reference variableswere considered
10-year risk of CV diseases ≥7.5%, ≥10%, and ≥20%.
Then 3 ROC analyses were conducted based on each
of above 3 thresholds, as reference variables, separately.
The plotted points formed the ROC curves and the areas
under the curve (AUCs) were computed to determine the
discriminatory accuracy of each of the 5 obesity measures
(WC, WHR, WHtR, AVI, and CI) in the diagnosis of
the individuals with 10-year risk ≥7.5%, ≥10%, and ≥20%.
Receiver operating characteristic analyses were performed
on reference variables computed using both ACC/AHA and
Framingham approaches separately.
All statistical analyses were conducted using Stata
software, version 12 (StataCorp, College Station, TX). The
rocreg (ROC regression) package of Stata software was
used to create the ROC curves and related comparisons.
Results
Association of Demographic Data, Anthropometric
Measurements, Anthropometric Indices, and Markers
of Metabolic Impact According to Sex
The demographic details, anthropometric measurements,
and laboratory and blood pressure data of participants
are presented in Table 1. There was a preponderance of
men (n= 1824; 57%), with age, weight, and height being
significantly higher (P < 0.05) than in women. Among
the central obesity indices, CI showed no sex differences
(P = 0.443). However, WHR in men (P < 0.001) and WC,
WHtR, and AVI in women were significantly higher
(P < 0.001). Women also showed significantly higher HC
and markers of metabolic impact: diastolic blood pressure
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Figure 1. A schematic diagram of the study participants. Abbreviations: ASCVD, atherosclerotic cardiovascular disease; MI, myocardial infarction.
(DBP), systolic blood pressure (SBP), FBS, TG, total
cholesterol, LDL-C, and HDL-C (P < 0.05).
Table 2 shows the prevalence of 10-year risk≥7.5%,≥10%,
and≥20% based on estimations of instruments of ACC/AHA
and Framingham, of which the former estimations were
significantly higher than the latter in both sexes (P < 0.05).
However, the κ coefficients were found to show substantial
agreement (>0.7) between the estimation of both tools for
the 10-year risk of ≥7.5% and ≥10% men compared with
women. The agreement values between the 2 instruments
were decreased from the risk estimation of ≥7.5% to 20% in
both sexes.
Areas Under the Curve for Obesity Indices With American
College of Cardiology/American Heart Association
and Framingham Tools
In general, with both risk-assessment tools it was found that
all 5 obesity indices for men and women yielded ROC curves
of varying convexity relative to the reference line (Figures 2
and 3), suggesting discriminatory power of the indices.
Comparison of the Discriminatory Performance of Obesity
Indices
Three ROC analyses were separately performed on
reference variables that were calculated based on the
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Table 1. Baseline Demographic, Anthropometric, and Metabolic Characteristics of Study Participants Age 40 to 79 Years
Characteristics
Mean±SD in Total
Study Population
(n= 3201)
Mean±SD in
Men
(n= 1826)
Mean±SD in
Women
(n= 1375) P Valuea
Age, y 54.68± 10.08 55.10± 10.41 54.15± 9.59 0.003
Weight, kg 75.83± 13.78 76.76± 14.04 74.62± 13.33 <0.001
Height, cm 161.75± 9.70 167.45± 7.54 154.32± 6.89 <0.001
WC, cm 94.90± 11.42 93.80± 11.20 96.32± 11.53 <0.001
HC, cm 104.19± 9.70 101.01± 7.77 108.34± 10.35 <0.001
DBP, mm Hg 78.63± 13.07 78.08± 13.09 79.34± 13.01 0.004
SBP, mm Hg 120.40± 17.72 119.51± 17.07 121.57± 18.48 0.004
FBS, mg/dL 107.88± 41.96 103.36± 35.58 113.76± 48.55 <0.001
TG, mg/dL 151.37± 102.89 149.56± 98.71 153.76± 107.96 <0.001
TC, mg/dL 193.91± 42.78 188.50± 41.30 200.95± 43.52 <0.001
LDL-C, mg/dL 114.65± 31.38 111.86± 30.91 118.28± 31.57 <0.001
HDL-C, mg/dL 43.12± 11.84 42.23± 11.65 44.27± 12.03 <0.001
BMI, kg/m2 28.89± 5.04 27.14± 4.27 31.18± 5.05 <0.001
WHR 0.911± 0.077 0.928± 0.0736 0.890± 0.0781 <0.001
WHtR 0.589± 0.0802 0.561± 0.0690 0.625± 0.0786 <0.001
AVI 18.37± 4.39 17.92± 4.19 18.97± 4.56 <0.001
CI 1.275± 0.0891 1.274± 0.0805 1.275± 0.099 0.443
Abbreviations: AVI, abdominal volume index; BMI, body mass index; CI, conicity index; DBP, diastolic blood pressure; FBS, fasting blood sugar; HC,
hip circumference; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; SBP, systolic blood pressure; SD, standard
deviation; TC, total cholesterol; TG, triglycerides; WC, waist circumference; WHR, waist-to-hip ratio; WHtR, waist-to-height ratio.
aSignificance level for difference between men and women was P< 0.05.
ACC/AHA tool (according to risk thresholds of 7.5%,
10%, and 20%), and another 3 analyses were performed
on reference variables that were calculated based on the
Framingham tool. All analyses were performed on data of
men and women separately.
In men, using the ACC/AHA tool, the CI had significantly
more discriminatory accuracy than other obesity indices
(P values for all comparisons were <0.001). The AUCs of
CI were 0.6713 (95% confidence interval: 0.64651-0.69604),
0.6727 (95% confidence interval: 0.64816-0.69714), and
0.6820 (95% confidence interval: 0.65459-0.70949) to
discriminate the individuals who had the 10-year risk≥7.5%,
≥10%, and ≥20%, respectively. On the other hand, using the
Framingham risk score, CI showed a significantly higher
performance (P < 0.05) than other obesity indices except for
the discrimination of the 10-year risk≥%20when it was com-
pared with WHR (P = 0.1089) and WHtR (P = 0.0936). The
AUCs of CI were 0.6514 (95% confidence interval: 0.62638-
0.67641), 0.6570 (95% confidence interval: 0.63206-0.68194),
and 0.6586 (95% confidence interval: 0.62295-0.69420) for
10-year risk ≥7.5%, ≥10%, and ≥20%, respectively.
In women, using the ACC/AHA tool, the discriminatory
power of CI was again significantly greater than that
of the other obesity indices. The AUCs of CI were
0.7285 (95% confidence interval: 0.69951-0.75741), 0.7359
(95% confidence interval: 0.70465-0.76710), and 0.7694
(95% confidence interval: 0.72380-0.81507) to discriminate
the patients who had a 10-year risk ≥7.5%, ≥10%, and
≥20%, respectively. Applying the Framingham approach,
a significantly higher performance was also computed
for CI compared with other obesity indices except WHR.
The P values for all significant comparisons were <0.001.
Finally, the AUCs of CI were 0.7260 (95% confidence
interval: 0.68434-0.76765), 0.7463 (95% confidence interval:
0.69701-0.79568 l), and 0.8292 (95% confidence interval:
0.73849-0.91991) in the discrimination of 10-year risk ≥7.5%,
≥10%, and ≥20%, respectively. More details are displayed in
Figures 2 and 3.
Discussion
Our results revealed that the central obesity indices have
discriminatory power to estimate the risk of CV diseases.
Among 5 central obesity indices, CI and WHR had the
strongest discriminatory power in men and women. The
present study also confirms that a large part of our
participants, predominantlymen,will be at risk of developing
CV events over the next decade. Further, our data showed
a high level of agreement between the Framingham and
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Table 2. Prevalence of 10-Year CV Risk ≥7.5%, ≥10%, and ≥20% According to Sex and Age
Risk Probability
10-Year ACC/AHA Risk
(95% Confidence Interval)
10-Year Framingham Risk
(95% Confidence Interval) P Valuea
10-year risk ≥7.5%
Men 61.9 (59.6-64.1) 58.1 (55.8-0.60.4) 0.0208
κ= 0.8153, SE= 0.0233
Women 26.5 (24.1-28.8) 9.3 (7.8-10.8) <0.0001
κ= 0.4295, SE= 0.0224
10-year risk ≥10%
Men 53.5 (51.2- 55.8) 48.9 (46.6-51.2) 0.0057
κ= 0.7756, SE= 0.0233
Women 20.1 (18.0-22.2) 5.7 (4.5-6.9) <0.0001
κ= 0.3740, SE= 0.0213
10-year risk ≥20%
Men 28.1 (26.0-30.2) 14.4 (12.8-16.0) <0.0001
κ= 0.4864, SE= 0.0215
Women 6. 8 (5.4-8.1) 1.0 (0.5-1.5) <0.0001
κ= 0.2484, SE= 0.0178
Abbreviations: ACC/AHA, American College of Cardiology/American Heart Association; CV, cardiovascular; SE, standard error.
κ is the agreement coefficient between the 2 tools for 10-year CV risk of ≥7.5%, ≥10%, as well as 10-year risk of ≥20%.
aP values are for all comparisons between the ACC/AHA and Framingham tools using the 2-sample proportion test to determine whether ACC/AHA and
Framingham tools produce the same proportion of 10-year risk of ≥7.5%, ≥0%, or ≥20%.
ACC/AHA approaches, particularly for the 10-year risk
≥10% in men.
Although central obesity is not directly used to estimate
risk of CV events in the 2 instruments used in the
study, our findings confirm the relative merit of their
discriminatory power in the estimation of these events.
Previous studies have confirmed the association between
obesity measures and CV diseases.13–16 However, our
study revealed that WC and AVI were the poorest
discriminators, with WHtR having some discriminatory
potential in the Framingham 10-year risk ≥20% tool. In
the case of the latter index, a meta-analysis study of
88 000 individuals showed the statistical superiority ofWHtR
relative to WC and WHR in detecting CV risk factors in
both men and women.17 With WC, previous studies on this
measure andCV risk have produced conflicting results.18–20
Although identical measures were included in the WHR
and AVI formula, the present study revealed that the latter
does not seem to be a good discriminatory index for the
10-year CV events. Despite the fact that identical variables
are involved to calculate these 2 indices, different algebraic
operations are used to adjust theWC in each of these indices.
In theWHR, the inverse of theHC serves for adjustment; but
in AVI,WC−HC is used, which means that a more rigorous
approach was used to adjust the WC in WHR formula
comparedwith AVI. Conicity index as a higher discriminator
index has 1 or 2 additional measures, compared with other
indices of obesity. However, despite this advantage, no
sex-discriminating body-shape measure is included in the
CI formula for the estimation of central obesity. Finally,
although CI had the highest discriminatory power, WHR,
with a lesser data requirement, portrayed itself as an almost
comparable discriminator of CV disease risk in the Iranian
study population of Amol. Other published literature also
noted the comparative merit of WHR as a central obesity
index that is associated with higher coronary risk.21–24
However, the results of various studies with regard to the
obesity indices used in predicting risk of CV diseases are
inconsistent.16,17,25–27
The present study estimated a large part of our population,
particularlymen, will be at risk of developing CV events over
the next decade; however, a lower risk was estimated by
Framingham compared with the ACC/AHA approach. The
recently introduced ACC/AHA tool additionally includes an
estimation of first severe ASCVD events (defined as first
occurrence of nonfatal myocardial infarction or CHD death,
or fatal or nonfatal stroke) rather than just being limited to
a CHD outcome alone, as in the Framingham tool, and this
may account for higher estimation.5
Although the values of the κ coefficient were relatively
high in men, this degree of agreement was relatively
lower in women. As discussed above, the Framingham
risk approach is more conservative than the ACC/AHA
approach in the estimation of risk, and also our study did
estimate a lower CV risk in women. As a result, when we
converted the continuous risk to a dichotomous value, a
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Figure 2. The ROC curves for discriminatory accuracy of central obesity indexes for 10-year risk of CV disease events using the ACC/AHA tool. The A-C
graphs are related to 10-year risks ≥7.5%, ≥10%, and ≥20%, respectively, in men, and D-F are related to identical outcomes in women. Abbreviations:
ACC/AHA, American College of Cardiology/American Heart Association; AVI, abdominal volume index; CI, conicity index; CV, cardiovascular; ROC, receiver
operating characteristic; WC, waist circumference; WHR, waist-to-hip ratio; WHtR, waist-to-height ratio.
greater portion of the women were classified as the low-risk
category according to the Framingham approach compared
with that of ACC/AHA.
In theory, the ACC/AHA instrument has several advan-
tages over Framingham tool. For instance, in the calculation
of final risk probability, the ACC/AHA approach uses the
exponential function, and as a consequence it gives the con-
tinuous values for risk estimation. The range of probability
in the ACC/AHA approach varies continuously from 0 to 1,
but in the Framingham approach it varies discretely to 0.3.
The continuous values in risk estimation that range from
0 to 1 without any limitation can lead to a more precise
estimation of risks at both the individual and community
levels. More precise estimations can help decision-makers
to consider and intervene with more timely and efficient
health strategies to implement preventive, therapeutic, and
rehabilitative programs against the burden of CV events in
the future. In clinical practice it also helps clinicians have
a better estimation of clinical status of their patients.
Given the lack of data, particularly with regard to the
recent ACC/AHA guidelines, we used Caucasian race as
suggested to estimate the 10-year ASCVD risk.5 To our
knowledge, our study is the first attempt to delineate the
ASCVD risk among a representative sample of a North
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Figure 3. ROC curves for discriminatory accuracy of central indexes for 10-year risk of CV diseases events using the Framingham tool. Panels A–C are
related to 10-year risks ≥7.5%, ≥10%, and ≥20%, respectively, in men, and panels D–F are related to identical outcomes in women. Abbreviations: AVI,
abdominal volume index; CI, conicity index; CV, cardiovascular; WC, waist circumference; WHR, waist-to-hip ratio; WHtR, waist-to-height ratio.
Iranian population. Our study group averages according to
sex and age can serve as reliable estimations of absolute
risk and can potentially be applied to individual patients
in practice, providing them with intervening choices for
initiating preventive strategies alongside potential public
health gains in tacklingmajor nationalCVhealth imperatives
in developing countries.
Study Limitations
Our study had some limitations, the most crucial being that
it was of a cross-sectional design. Our approach requires
validation with the use of prospective studies. Further, the
study was confined to participants in Amol, Northern Iran,
hence this may limit generalizing our findings to other
regions of the Iranian population. However, this may have
the advantage of minimizing any confounding variables
regarding variations in medical care and access, varying
socioeconomic strata, and others. Another important
limitation linked to our cross-sectional design is that our
study did not accommodate for temporality. Hence, a
time relationship of whether risk factors of CV disease
follow enhanced adiposity, or vice versa, could not be
established as would be possible with a prospective
study.
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Conclusion
Conicity index had the most discriminatory accuracy for
the 10-year CV events compared with the other obesity
indices. In clinical practice, this index can be measured
using a few simple and routine measurements. In the
same way, the WHR, with a requirement for even fewer
measurements in clinical approaches, revealed a relatively
good discriminatory power.
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